Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...
In April 2023, 23andMe was targeted in a hack that exposed the personal data of 6.9 million customers. The company agreed to ...
“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...
Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...
As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.
“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback